Advertisement

Erratum to systematic review and critical evaluation of quality of clinical practice guidelines on the management of SARS-CoV-2 infection in pregnancy

      The publisher regrets that the authors corrections regarding structural errors in Tables 1 and 2 were not incorporated during the proofing stage. There seems to be some overlap between these tables and the supplementary tables. Furthermore, Table 3 and Figure 1 were incorrect. Please refer to the corrected table and figure files below.
      Table 1General characteristics of the CPGs included in the quantitative analyses of systematic review
      Di Girolamo. Management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM 2022.
      First author or societyYearCountryTitleSocietyScopeDate of publicationNumber of revisionsMethod of development
      CAPWHN,6 20202020CanadaSuggestions for the care of the perinatal populationCanadian Association of Perinatal and Women's Health NursesNational20200Expert opinion, methods not reported
      Chawla,11 20202020IndiaPerinatal-neonatal management of COVID-19 infectionFederation of Obstetric and Gynaecological Societies of India, National Neonatology Forum of India, and Indian Academy of PediatricsNational20200Review of literature, expert panel consensus, GRADE
      Elwood,12 20202020CanadaCommittee Opinion No. 400: COVID-19 and pregnancyThe Society of Obstetricians and Gynaecologists of CanadaNational20212Review of literature, expert panel consensus, methods not reported
      CDC,13 20202020United StatesCOVID-19 vaccines while pregnant or breastfeedingCenters for Disease Control and PreventionNational20213Methods not reported
      ACOG,14 20202020United StatesCOVID-19 vaccination considerations for obstetric–gynecologic careAmerican College of Obstetricians and GynecologistsNational20213Review of literature, expert panel consensus, methods not reported
      Miller,15 20202020United KingdomSociety for Maternal-Fetal Medicine and Society for Obstetric and Anesthesia and Perinatology labor and delivery COVID-19 considerationThe Society for Maternal-Fetal MedicineNational20217Expert opinion, methods not reported
      RANZCOG,16 20202020AustraliaCoronavirus disease (COVID-19) in pregnancy: a guide for resource-limited environmentsThe Royal Australian and New Zealand College of Obstetricians and GynaecologistsNational20203Review of literature, expert panel consensus, methods not reported
      NSW,18 20202020AustraliaGuidance for maternity, newborn care and infant feeding, medicine management for pregnant patients with COVID-19New South Wales Government HealthLocal20213Review of literature, expert panel consensus, methods not reported
      Quebec Group,19 20202020CanadaGuidelines for the management of the pregnant woman with COVID-19 admitted to the intensive care unit (ICU)Quebec Maternal-Fetal Medicine GroupLocal20200Expert panel consensus, methods not reported
      Government of India,20 20212021IndiaGuidelines on operationalization of maternal health services during COVID-19 pandemicMaternal Health Division Ministry of Health and Family WelfareNational20210Methods not reported
      Indian Council of Medical Research,21 20202020IndiaGuidance for management of pregnant women in COVID-19 pandemicNational Institute for Research in Reproductive HealthNational20200Expert panel consensus, methods not reported
      Bahtiyar,22 20212021United StatesFetal interventions in the setting of the coronavirus disease 2019 pandemic: statement from the North American Fetal Therapy NetworkNorth American Fetal Therapy NetworkNational20210Expert opinion, methods not reported
      Poon,25 20202020NSISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals – an updateInternational Society of Ultrasound in Obstetrics and GynecologyInternational20201Review of literature, expert panel consensus, methods not reported
      Bourne,26 20202020NSISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2International Society of Ultrasound in Obstetrics and GynecologyInternational20201Review of literature, expert panel consensus, methods not reported
      RCOG,27 20202020United KingdomGuidance for antenatal screening and ultrasound in pregnancy in the coronavirus (COVID-19) pandemicRoyal College of Obstetricians and GynaecologistsNational20211.2Review of literature, expert panel consensus, methods not reported
      RCOG,28 20212021United KingdomGuidance for rationalising early pregnancy services in the evolving coronavirus (COVID-19) pandemicRoyal College of Obstetricians and GynaecologistsNational20212Expert panel consensus, methods not reported
      RCOG,29 20212021United KingdomCoronavirus (COVID-19) infection and pregnancyRoyal College of Obstetricians and GynaecologistsNational202214.3Expert panel consensus, searching through literature
      HIS,31 20202020United KingdomCOVID-19 position statement: maternal critical care provisionHealthcare Improvement ScotlandNational20202Expert opinion, methods not reported
      SIGO and AOGOI,32 20212021ItalyInterim guidance on pregnancy,childbirth, breastfeeding and careof infants (0-2 years) in responseto the COVID-19 emergencyItalian Society of Gynaecology and Obstetrics and Association of Italian HospitalGynaecologists and ObstetriciansNational20212Review of literature, expert panel consensus, methods not reported
      GRADE, Grading of Recommendations Assessment, Development and Evaluation; NS, not specified.
      Table 2AGREE-ment score was showed
      Di Girolamo. Management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM 2022.
      ID AGREE IIDomain 1 (items 1–3)Domain 2 (items 4–6)Domain 3 (items 7–14)Domain 4 (items 15–17)Domain 5 (items 18–21)Domain 6 (items 22–23)OA1OA2
      CAEP.CA586%0%0%24%32%29%0%Y (n=0)

      YWM (n=0)

      N (n=2)
      CAPWHN686%43%21%48%32%64%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      AAFP786%0%0%24%32%29%0%Y (n=0)

      YWM (n=0)

      N (n=2)
      CPS886%43%21%48%32%64%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      AAP943%38%38%48%50%50%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      CDC1090%81%59%90%61%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      FOGSI, NNF, and IAP1186%76%64%67%57%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      SOGC1290%57%70%57%57%43%57%Y (n=1)

      YWM (n=1)

      N (n=0)
      CDC1390%81%59%90%61%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      ACOG1490%57%70%62%54%43%57%Y (n=1)

      YWM (n=1)

      N (n=0)
      SMFM1586%43%54%86%67%50%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      RANZCOG1686%62%64%52%54%36%57%Y (n=1)

      YWM (n=1)

      N (n=0)
      FIGO1781%38%59%67%43%64%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      NSW1886%48%27%52%61%57%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      Quebec Group1943%38%38%48%50%50%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      GOI2086%43%21%48%32%64%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      ICMR2186%0%0%24%32%29%0%Y (n=0)

      YWM (n=0)

      N (n=2)
      NAFTN2243%38%38%48%50%50%43%Y (n=2)

      YWM (n=2)

      N (n=0)
      EBCOG2390%57%59%52%54%43%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      ISIDOG2443%43%21%48%32%29%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      ISUOG2590%81%59%52%61%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      ISUOG2690%57%70%62%54%57%57%Y (n=1)

      YWM (n=1)

      N (n=0)
      ISUOG2786%76%64%67%57%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      RCOG2890%57%70%57%57%50%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      RCOG2990%76%59%48%61%64%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      RCOG3090%81%59%90%61%43%71%Y (n=2)

      YWM (n=0)

      N (n=0)
      HIS3186%43%21%48%32%64%43%Y (n=0)

      YWM (n=2)

      N (n=0)
      SIGO and AOGOI3290%71%59%52%61%29%57%Y (n=1)

      YWM (n=1)

      N (n=0)
      Average score for each domain
      A cutoff for high-quality clinical practise guidelines (CPGs) of ≥60% for all 6 AGREE II domains was selected in consideration of the limitations associated with the development of rapid guidelines. The cutoffs for low quality and moderate quality are <40% and 40% to 60%, respectively. The cutoffs for high quality are >60%.
      81%51%44%56%49%47%50%
      Standard deviation for each domain16%24%23%18%12%12%21%
      AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACOG, American College of Obstetricians and Gynecologists; AGREE II, Appraisal of Guidelines, Research and Evaluation; AOGOI, Association of Italian Hospital Gynaecologists and Obstetricians; CAEP.CA, Canadian Association of Emergency Physicians; CAPWHN, Canadian Association of Perinatal and Women's Health Nurses; CDC, Centers for Disease Control and Prevention; CPS, Canadian pediatric Society; EBCOG, European Board and College of Obstetrics and Gynaecology; FIGO, International Federation of Gynaecology and Obstetrics; FOGSI, Federation of Obstetric and Gynaecological Societies of India; GOI, Government of India; HIS, Healthcare Improvement Scotland; IAP, Indian Academy of Pediatrics; ICMR, Indian Council of Medical Research; ISIDOG, International Society of Infectious Diseases in Obstetrics and Gynecology; ISUOG, International Society of Ultrasound in Obstetrics and Gynecology; N, no; NAFTN, North American Fetal Therapy Network; NNF, National Neonatology Forum of India; NSW, New South Wales Government Health; OA1, overall guideline assessment 1; OA2, overall guideline assessment 2; RANZCOG, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists; RCOG, Royal College of Obstetricians and Gynaecologists; SIGO, Italian Society of Gynaecology and Obstetrics; SMFM, Society for Maternal-Fetal Medicine; SOGC, Society of Obstetricians and Gynaecologists of Canada; Y, yes; YWM, yes with modifications.
      a A cutoff for high-quality clinical practise guidelines (CPGs) of ≥60% for all 6 AGREE II domains was selected in consideration of the limitations associated with the development of rapid guidelines. The cutoffs for low quality and moderate quality are <40% and 40% to 60%, respectively. The cutoffs for high quality are >60%.
      Table 3Graphic description of issues addressed by eligible rapid guidelines for antenatal care management of pregnant women with COVID-19
      Di Girolamo. Management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM 2022.
      GuidelineCAPWHN6FOGSI, NNF, and IAP11SOGC12CDC13ACOG14SMFM15RANZCOG16NSW18GMFMQ19GOI20ICMR21NAFTN22ISUOG25ISUOG26RCOG27RCOG28RCOG29HIS31SIGO32
      Year2020202020202020202020202020202020202021202020212020202020202021202220202021
      Maternal hospitalization criteria for COVID-19XXXXXX
      Maternal hospitalization criteria for obstetrical conditionsXXXXXX
      Ultrasound scan soon after recoveryXXXXXX
      Monthly surveillance during pregnancy after recoveryXXXXX
      Specific recommendations against invasive proceduresX
      Use of antenatal anticoagulation with LMWHXXXXXXXX
      Send placenta to histopathologyX
      Corticosteroids for COVID-19 symptomsXXXXX
      Other supportive therapies during laborXXXXXXXXXXXX
      Continuous fetal electronic monitoringXXXXXXX
      Induction of labor at 39 weeksXX
      Indication for cesarean delivery for COVID-19 symptomsXXX
      Shortening of the second stage of laborXX
      Active pushingX
      Postpartum care: is use of LMWH encouraged?X
      Vaccine boosterXXXXX
      ACOG, American College of Obstetricians and Gynecologists; CAPWH, Canadian Association of Perinatal and Women's Health Nurses; CDC, Centers for Disease Control and Prevention; FOGSI, Federation of Obstetric and Gynaecological Societies of India; GOI, Government of India; HIS, Healthcare Improvement Scotland; IAP, Indian Academy of Pediatrics; ICMR, National Institute for Research in Reproductive Health; ISUOG, International Society of Ultrasound in Obstetrics and Gynecology; LMWH, low-molecular-weight heparin; NAFTN, North American Fetal Therapy Network; NNF, National Neonatology Forum of India; NSW, New South Wales Government Health; RANZCOG, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists; RCOG, Royal College of Obstetricians and Gynaecologists; SIGO, Italian Society of Gynaecology and Obstetrics; SMFM, Society for Maternal-Fetal Medicine; SOGC, Society of Obstetricians and Gynaecologists of Canada.
      Figure
      Figure 1PRISMA flow chart
      Di Girolamo. Management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM 2022.
      CPG, Clinical practise guideline.

      Linked Article